The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...
The Iowa House passed a wide-ranging health policy bill Tuesday in a 65-30 vote, moving Iowans closer to expanded access to ...
CANTANHEDE, PORTUGAL, NEW YORK CITY, USA AND DUBLIN, IRELAND, January 12, 2026 /EINPresswire.com/ — • An early-phase clinical study designed to characterise bio ...
Cervical cancer remains a leading cause of cancer-related death among women globally, despite the availability of effective prevention through human papillomavirus (HPV) vaccination and HPV-based ...
The recent Union Budget has signalled a tectonic shift in the Indian pharmaceutical landscape. With the launch of Biopharma SHAKTI (Strategy for Healthcare Advancement through Knowledge, Technology, ...
Single-dose HPV vaccine offers hope, uptake remains low Cervical cancer remains a major public health challenge in Kenya, with nearly 6,000 women diagnosed and more than 3,500 losing their lives to ...
Kenya’s transition to a single-dose HPV vaccine supports WHO’s Global Strategy to Accelerate the Elimination of Cervical Cancer, which targets 90 per cent of girls fully vaccinated by age 15. Globally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results